PMMB-302

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NamePMMB-302
Drug Alias NamePMMB-302
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTelomerase inhibitors
TargetsTelomerase
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNanjing University
China Registration ClassN/A

Develop Information

Active CompaniesNanjing University
Inactive CompaniesN/A
Active IndicationsLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A